高级检索
当前位置: 首页 > 详情页

Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.

文献详情

资源类型:
Pubmed体系:
机构: [1]CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing [2]Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University [3]Department of Radiology, Henan Provincial People’s Hospital [4]Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University [5]Department of Radiology, Key Laboratory of Intelligent Medical Image Analysis and Precision Diagnosis in Guizhou Province, Guizhou Provincial People’s Hospital [6]University of Chinese Academy of Sciences, Beijing, China and [7]Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, 100191, china
出处:
ISSN:

关键词: Deep learning High-grade serous ovarian cancer Recurrence Prognosis Computed tomography Artificial intelligence Semi-supervised learning Auto encoder Unsupervised learning

摘要:
Recurrence is the main risk for high-grade serous ovarian cancer (HGSOC) and few prognostic biomarkers were reported. In this study, we proposed a novel deep learning (DL) method to extract prognostic biomarkers from preoperative computed tomography (CT) images, aiming at providing a non-invasive recurrence prediction model in HGSOC. We enrolled 245 patients with HGSOC from two hospitals, which included a feature-learning cohort (n = 102), a primary cohort (n = 49) and two independent validation cohorts from two hospitals (n = 49 and n = 45). We trained a novel DL network in 8917 CT images from the feature-learning cohort to extract the prognostic biomarkers (DL feature) of HGSOC. Afterward, a DL-CPH model incorporating the DL feature and Cox proportional hazard (Cox-PH) regression was developed to predict the individual recurrence risk and 3-year recurrence probability of patients. In the two validation cohorts, the concordance-index of the DL-CPH model was 0.713 and 0.694. Kaplan-Meier's analysis clearly identified two patient groups with high and low recurrence risk (p = 0.0038 and 0.0164). The 3-year recurrence prediction was also effective (AUC = 0.772 and 0.825), which was validated by the good calibration and decision curve analysis. Moreover, the DL feature demonstrated stronger prognostic value than clinical characteristics. The DL method extracts effective CT-based prognostic biomarkers for HGSOC, and provides a non-invasive and preoperative model for individualized recurrence prediction in HGSOC. In addition, the DL-CPH model provides a new prognostic analysis method that can utilize CT data without follow-up for prognostic biomarker extraction. Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 核医学 2 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
第一作者:
第一作者机构: [1]CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing [6]University of Chinese Academy of Sciences, Beijing, China and
共同第一作者:
通讯作者:
通讯机构: [1]CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing [2]Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University [3]Department of Radiology, Henan Provincial People’s Hospital [6]University of Chinese Academy of Sciences, Beijing, China and [7]Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, 100191, china [*1]Department of Radiology, Henan Provincial People’s Hospital, China [*2]Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, China [*3]CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号